Breast conserving therapy for early breast cancer. Brachytherapy or proton beam boost: a randomized study

2002 ◽  
Vol 38 (11) ◽  
pp. S149
Author(s):  
M Greco
Keyword(s):  
Breast Cancer ◽  
Proton Beam ◽  
Early Breast Cancer ◽  
Randomized Study ◽  
Breast Conserving Therapy

A feasibility study of a hybrid breast-immobilization system for early breast cancer in proton beam therapy

2017 ◽  
Vol 44 (4) ◽  
pp. 1268-1274 ◽  
Author(s):  
Takeshi Arimura ◽  
Takashi Ogino ◽  
Takashi Yoshiura ◽  
Mitsugi Matsuyama ◽  
Naoaki Kondo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Proton Beam ◽  
Early Breast Cancer ◽  
Feasibility Study ◽  
Proton Beam Therapy

COSMETIC OUTCOME OF BREAST-CONSERVING THERAPY IN CHINESE PATIENTS WITH EARLY BREAST CANCER

1997 ◽  
Vol 67 (11) ◽  
pp. 771-774 ◽  
Author(s):  
W. Yeo ◽  
W. H. Kwan ◽  
P. M. L. Teo ◽  
W. T. Leung ◽  
W. King ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Breast Conserving Therapy ◽  
Cosmetic Outcome ◽  
Chinese Patients

Impact of Sequencing Radiation Therapy and Chemotherapy on Long-term Local Toxicity for Early Breast Cancer: Results of a Randomized Study at 15-Year Follow-up

2015 ◽  
Vol 93 (3) ◽  
pp. S223-S224
Author(s):  
P. Pinnaro ◽  
C. Giordano ◽  
A. Farneti ◽  
L. Strigari ◽  
V. Landoni ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Early Breast Cancer ◽  
Randomized Study ◽  
Local Toxicity

scholarly journals A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancer

The Breast ◽  
2011 ◽  
Vol 20 (4) ◽  
pp. 334-337 ◽  
Author(s):  
Dalia ELFadl ◽  
Victoria C. Hodgkinson ◽  
Ervine D. Long ◽  
Lucy Scaife ◽  
Philip J. Drew ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Pilot Study ◽  
Early Breast Cancer ◽  
Breast Conserving Therapy ◽  
26S Proteasome ◽  
Regional Recurrence ◽  
Radiotherapy Resistance

scholarly journals PV-0044 Mastectomy or breast-conserving therapy for early breast cancer: outcome comparison of 7565 cases

2019 ◽  
Vol 133 ◽  
pp. S14-S15
Author(s):  
S. Corradini ◽  
M. Pazos ◽  
D. Reitz ◽  
S. Schönecker ◽  
M. Niyazi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Breast Conserving Therapy ◽  
Breast Cancer Outcome ◽  
Outcome Comparison ◽  
Cancer Outcome

scholarly journals PO-0683: Electron IntraOperative RadioTherapy (ELIOT) in early breast cancer: Outcome analysis of a non-randomized study

2015 ◽  
Vol 115 ◽  
pp. S334-S335
Author(s):  
L. Cazzaniga ◽  
G. Gritti ◽  
A. Gambirasio ◽  
M. Källi ◽  
F.R. Filippone ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Randomized Study ◽  
Intraoperative Radiotherapy ◽  
Outcome Analysis ◽  
Breast Cancer Outcome ◽  
Cancer Outcome

Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute.

1992 ◽  
Vol 10 (6) ◽  
pp. 976-983 ◽  
Author(s):  
A S Lichter ◽  
M E Lippman ◽  
D N Danforth ◽  
T d'Angelo ◽  
S M Steinberg ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Study ◽  
Breast Conservation ◽  
Disease Free Survival ◽  
Excisional Biopsy ◽  
Breast Conserving Therapy ◽  
Stage I ◽  
Breast Cancer Patients ◽  
Tumor Bed ◽  
Local Regional Control

PURPOSE Mastectomy versus excisional biopsy (lumpectomy) plus radiation for the treatment of stage I and II breast cancer was compared in a prospective randomized study. PATIENTS AND METHODS From 1979 to 1987, 247 women were randomized and 237 were treated on this study. All patients received a full axillary dissection and all node-positive patients received adjuvant chemotherapy with cyclophosphamide and doxorubicin. Radiation consisted of external-beam therapy to the whole breast with or without supraclavicular nodal irradiation followed by a boost to the tumor bed. RESULTS The minimum time on the study was 18 months and the median time on the study was 68 months. No differences in overall survival or disease-free survival were observed. Actuarial estimates at 5 years showed that 85% of mastectomy-treated patients were alive compared with 89% of the lumpectomy/radiation patients (P2 = .49; 95% two-sided confidence interval [CI] about this difference, 0% to 9% favoring lumpectomy plus radiation). The probability of failure in the irradiated breast was 12% by 5 years and 20% by 8 years according to actuarial estimates. Of 15 local breast failures, 14 were treated with and 12 were controlled by mastectomy; the ultimate local-regional control was similar in both arms of the trial. CONCLUSION These data add further weight to the conclusion that breast conservation using lumpectomy and breast irradiation is equivalent to mastectomy in terms of survival and ultimate local control for stage I and II breast cancer patients.

Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer

2002 ◽  
Vol 347 (16) ◽  
pp. 1227-1232 ◽  
Author(s):  
Umberto Veronesi ◽  
Natale Cascinelli ◽  
Luigi Mariani ◽  
Marco Greco ◽  
Roberto Saccozzi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Randomized Study ◽  
Radical Mastectomy ◽  
Breast Conserving Surgery
Sign in / Sign up

Export Citation Format

Share Document